Information portal on various topics of management of public resources of the Portuguese State

Project sheet

Name

Assistant Professor in Pharmaceutical Microbiology

Total project amount

84,78 thousand €

Amount paid

84,78 thousand €

Non-refundable funding

84,78 thousand €

Loan funding

0 €

Start date

20.06.2025

Expected end date

31.03.2026

Dimension

Resilience

Component

Qualifications and Skills

Investment

Science Plus Training

Operation code

02/C06-i06/2024.P2023.15190.TENURE.005

Summary

??????? Job DescriptionFor this position, the employee/candidate is expected to:Design, plan and lead studies on the genomic epidemiology of bacterial pathogens such as Mycobacterium tuberculosis and Klebsiella pneumoniae including the analysis of dissemination and emergence using state-of-the-art typing methods and whole-genome sequencing;Participate and/or lead research networks or initiatives, of both national and international scope, envisioning the characterization of international and national dissemination patterns of relevant pathogens;Undertake complex bioinformatic analysis of whole-genome sequencing data as well as phylogenetic reconstruction and time-scaled phylogenetic reconstruction;Develop, implement and validate bioinformatic pipelines along with novel bioinformatic tools that can facilitate the analysis and integration of NGS data, including large-scale genomics, for relevant bacterial species.;Characterize bacterial resistance mechanisms, detailing its molecular determinants, mechanisms of mobilization, if applicable, and genetic context. The candidate should be able to implement different phenotypic testing methods, as well as genotypic methods aimed at the elucidation of resistance mechanisms, clinical significance and emergence.Design, and planning of research projects within the scientific area, particularly, in molecular microbiology, genomic epidemiology and antimicrobial resistance;Coordinate and participate in the development and strengthening of laboratory infrastructure and capacity development on bioinformatics and generation of NGS data;Assist the research community at the host institution with the design and planning of antibacterial drug discovery activities;Collaborate and supervise teaching and training programmes at the institution, namely by collaborating in the teaching programme of curricular Units such as Bacteriology, Food Microbiology and Bioinformatics. It is also expected that the recipient of this position will develop and direct a PhD Advanced Course on Bioinformatics to improve NGS data handling capacity at the institution. Scientific profileThe candidate should demonstrate a good track record in the field of epidemiology and molecular drug resistance with particular emphasis in the molecular epidemiology of tuberculosis, genome-wide data analysis and good understanding of the molecular basis of resistance in Mycobacterium tuberculosis and correlation with clinical significance. Experience with additional bacterial pathogens is also preferred. Furthermore, the candidate must demonstrate capacity to lead a research team and conduct research activities with a high level of independence. The candidate must be able to design, plan and perform complex assays involving bacterial pathogens and extensive expertise in the characterization of drug susceptibility to different antibiotics. Knowledge of GNU/Linux systems and proficiency in shell scripting and R/Python programming is required along with skills in deploying open-source software, command-line interfacing for bioinformatic analysis of NGS data pipeline development. The candidate should have a strong background in pharmaceutical microbiology and molecular biology and be proficient in the implementation of molecular biology assays and manipulation of bacterial pathogens including demonstrated working experience under BSL-2 and BSL-3 facilities. In addition, the candidate should have teaching experience at the undergraduate and postgraduate level, with particular emphasis at teaching curricular units from Integrated Master’s in Pharmaceutical Sciences. ???????RationaleThe requested position is aligned with the disciplinary area of Pharmaceutical Microbiology and Infectious Diseases, a core area in the field of Pharmaceutical Sciences that encompasses aspects such as the action mechanisms of antimicrobial drugs, resistance mechanisms, pharmacology, epidemiology and mechanisms of pathophysiology associated with infectious agents. This is also a pivotal area at iMed.ULisboa and transversal to its three main hubs (Scientific, Technological and Translational) with innovative multipronged approaches aiming at the prevention, early detection and intervention against public health threats such as tuberculosis. Moreover, by converging the multidisciplinary research encompassed in this scientific profile to applied research, it is not only possible to gain insights on the fundamental biology of important pathogens but also to inform public health decision and disease clinical management. The position and scientific profile requested increases the interface of iMed.ULisboa and its host institution with multiple players in the healthcare sector, thus strengthening this research area at iMed.ULisboa, increasing its visibility and outreach, while simultaneously enhancing current teaching methodologies, ensuring these remain up to date.

Beneficiaries

Within the scope of the Recovery and Resilience Plan, two types of beneficiaries are responsible for carrying out the projects and using the funding provided. Due to their similar role, the reference to these two types of beneficiaries has been simplified and unified under the term "Beneficiary".
The two types are::
  • Direct Beneficiaries are those whose funding and projects to implement are part of the Recovery and Resilience Plan that has been negotiated and approved by the European Union;
  • Final Beneficiaries are those whose funding and projects to implement are approved following a selection process through Calls for Applications.

Call for applications

As part of the Call for Applications, submissions are requested to select the projects and final beneficiaries to whom funding will be awarded. Specific selection criteria are defined for each call, which must be reflected in the applications submitted and assessed.

The project is appraised on the basis of its compliance with the selection criteria laid down in the calls for applications, and a final score may be awarded, where applicable.

Final evaluation score

8,9
Important note

The components for calculating the assessment score can be found in the selection criteria document mentioned below.

Selection criteria

The funding selection criteria to which this project and its final beneficiary were subject and its score can be found in detail on the Recuperar Portugal platform.

Beneficiaries

Intermediate beneficiaries

Beneficiaries

Procurement

Beneficiaries representing public entities implement their project by signing one or more contracts with suppliers for goods or services through public procurement procedures.

To ensure and provide the utmost transparency in all these contracts, a list of the contracts that were signed under this project is available here, along with the information available on the Base.Gov platform. Please note that, according to the legislation in force at the time the contract was signed, some exceptions do not require the publication of the contracts signed on this platform, and, therefore, no information is available in such cases.

Geographic distribution

84,78 thousand €

Total amount of the project

Percentage of the amount already paid for implementing projects

, 100 %,

Where was the money spent

By county

1 county financed .

  • Lisboa 84,78 thousand € ,
Source EMRP
10.02.2026
All themes
Transparency without leading